AIM ImmunoTech, Inc. (AIM)
1.49
-0.03
(-1.97%)
USD |
NYAM |
Dec 09, 16:00
AIM ImmunoTech Total Assets (Quarterly): 5.494M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 294.82M |
| Protalix Biotherapeutics, Inc. | 82.26M |
| Electromed, Inc. | 53.61M |
| Xtant Medical Holdings, Inc. | 106.32M |
| Armata Pharmaceuticals, Inc. | 89.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.57M |
| Shareholders Equity (Quarterly) | -6.077M |
| Debt to Equity Ratio | -0.3847 |
| Current Ratio | 0.6369 |
| Net Debt Paydown Yield | 9.75% |